NDC 50242-140

ERIVEDGE

Vismodegib

ERIVEDGE is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Vismodegib.

• Product ID: 50242-140_342104f5-507e-42ed-9d8a-e2d3eb27599c
• NDC: 50242-140
• Product Type: Human Prescription Drug
• Proprietary Name: ERIVEDGE
• Generic Name: Vismodegib
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2012-01-30
• Marketing Category: NDA / NDA
• Application Number: NDA203388
• Labeler Name: Genentech, Inc.
• Substance Name: VISMODEGIB
• Active Ingredient Strength: 150 mg/1
• Pharm Classes: Hedgehog Pathway Inhibitor [EPC],Smoothened Receptor Antagonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 50242-140-01

1 BOTTLE, PLASTIC in 1 CARTON (50242-140-01) > 28 CAPSULE in 1 BOTTLE, PLASTIC

• Marketing Start Date: 2012-01-30
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 50242-140-01 [50242014001]

ERIVEDGE CAPSULE

• Marketing Category: NDA
• Application Number: NDA203388
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2012-01-30

NDC 50242-140-86 [50242014086]

ERIVEDGE CAPSULE

• Marketing Category: NDA
• Application Number: NDA203388
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2013-04-09

Drug Details

Active Ingredients

Ingredient	Strength
VISMODEGIB	150 mg/1

Pharmacological Class

• Hedgehog Pathway Inhibitor [EPC]
• Smoothened Receptor Antagonists [MoA]